<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">1</item><item key="sample_count">8</item><item key="tags"><item>carcinoma</item><item>colon</item><item>liver</item><item>liver metastasis</item></item><item key="slug">comparison-of-gene-expression-profiles-between-pai</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-18462</item><item key="species">human</item><item key="id">3441</item><item key="name">Comparison of gene expression profiles between paired primary and metastasis colorectal carcinoma</item></item><item><item key="factor_count">1</item><item key="sample_count">8</item><item key="tags"><item>cancer</item><item>liver</item><item>liver metastasis</item><item>melanoma</item><item>metastatic melanoma</item><item>solid</item><item>spleen</item></item><item key="slug">identification-of-genes-and-molecular-pathways-ass</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-24824</item><item key="species">human</item><item key="id">3840</item><item key="name">Identification of genes and molecular pathways associated with anti-miR-182 treatment.</item></item><item><item key="factor_count">7</item><item key="sample_count">23</item><item key="tags"><item>adenocarcinoma</item><item>cancer</item><item>ductal adenocarcinoma</item><item>integrin</item><item>liver</item><item>liver metastasis</item><item>pancreatic cancer</item><item>pancreatic ductal adenocarcinoma</item></item><item key="slug">molecular-markers-associated-with-outcome-and-meta</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-42952</item><item key="species">human</item><item key="id">2588</item><item key="name">Molecular markers associated with outcome and metastasis in human pancreatic cancer</item></item></data></biogps>
